Not Medicare Enrolled

Dr. Thomas Casale, M.D.

Allergy & Immunology · Tampa, FL
12901 BRUCE B DOWNS BLVD, Tampa, FL 33612
8139748954
Registered in NPPES since 2006
NPI: 1124132535 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Casale from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Casale? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Casale

Dr. Thomas Casale is an allergy & immunology specialist in Tampa, FL, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Casale received a total of $432,894 from 19 pharmaceutical and/or device companies across 374 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Casale is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $432,894 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 118533 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$432,894
Total received (2018-2024)
Avg $61,842/year across 7 years
Top 3% in FL for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
19
Companies
374
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$70,820
2023
$52,478
2022
$26,555
2021
$27,322
2020
$68,983
2019
$81,018
2018
$105,719

Payments by company (2024)

Genentech USA, Inc.
$29,425
GENZYME CORPORATION
$16,276
Novartis Pharmaceuticals Corporation
$16,050
Regeneron Pharmaceuticals, Inc.
$4,893
ALK-Abello, Inc
$2,800
Eli Lilly and Company
$800
Regeneron Healthcare Solutions, Inc.
$576
Top 3 companies account for 87.2% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$115,684
GENZYME CORPORATION
$87,603
F. Hoffmann-La Roche AG
$72,555
GlaxoSmithKline, LLC.
$47,485
Novartis Pharmaceuticals Corporation
$24,242
Genentech, Inc.
$19,341
AstraZeneca Pharmaceuticals LP
$11,691
Boehringer Ingelheim International GmbH
$9,269
Eli Lilly and Company
$7,200
NOVARTIS PHARMACEUTICALS CORPORATION
$6,075
SANOFI-AVENTIS U.S. LLC
$5,400
Amgen Inc.
$5,220
Regeneron Pharmaceuticals, Inc.
$5,216
Regeneron Healthcare Solutions, Inc.
$3,172
AstraZeneca AB
$3,150
ALK-Abello, Inc
$2,800
Novartis Pharma AG
$2,548
Aimmune Therapeutics, Inc.
$2,475
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,770
Top 3 companies account for 63.7% of all-time payments
Associated products mentioned in payments ›
ALBUFERON · Avastin · DUPIXENT · FASENRA · IGE025A_XOLAIR _RESPIRATORY · NUCALA · Odactra · PALFORZIA · SPIRIVA · SPIRIVA RESPIMAT · XOLAIR · Xolair
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an allergy & immunology specialist in Tampa?
Compare allergy & immunologists in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists in nearby ZIP areas
44
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
TAMPA VA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Casale is an allergy & immunology specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Casale receive payments from pharmaceutical companies?
Yes. Dr. Casale received a total of $432,894 from 19 companies across 374 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Casale) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →